Global Glycoprotein Market Growth 2023-2029

Global Glycoprotein Market Growth 2023-2029

Glycoproteins are proteins that contain oligosaccharide chains (glycans) covalently attached to polypeptide side-chains. The carbohydrate is attached to the protein in a cotranslational or posttranslational modification. This process is known as glycosylation. Secreted extracellular proteins are often glycosylated.
LPI (LP Information)' newest research report, the “Glycoprotein Industry Forecast” looks at past sales and reviews total world Glycoprotein sales in 2022, providing a comprehensive analysis by region and market sector of projected Glycoprotein sales for 2023 through 2029. With Glycoprotein sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Glycoprotein industry.
This Insight Report provides a comprehensive analysis of the global Glycoprotein landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Glycoprotein portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Glycoprotein market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Glycoprotein and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Glycoprotein.
The global Glycoprotein market size is projected to grow from US$ 463.3 million in 2022 to US$ 586.4 million in 2029; it is expected to grow at a CAGR of 586.4 from 2023 to 2029.
Glycoprotein is mainly manufactured and sold by Sigma, Creative Diagnostics, R&D Systems, Enzo Life Sciences, Thermo Fisher Scientific, Epitope Diagnostics, BD Biosciences. The top 3 companies occupy about 60% market share. North America is the largest production region in the world, which took more than 85 percent of the global market.
This report presents a comprehensive overview, market shares, and growth opportunities of Glycoprotein market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
N-linkage
O-linkage
Others
Segmentation by application
Hospital
Research Institutes
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Sigma
Creative Diagnostics
R&D Systems
Enzo Life Sciences
Thermo Fisher Scientific
Epitope Diagnostics
BD Biosciences
Key Questions Addressed in this Report
What is the 10-year outlook for the global Glycoprotein market?
What factors are driving Glycoprotein market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Glycoprotein market opportunities vary by end market size?
How does Glycoprotein break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.